Bamco Inc Sage Therapeutics, Inc. Transaction History

Bamco Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$26.15 - $77.24 $10.8 Million - $32 Million	-414,122 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$60.18 - $154.77 $694,116 - $1.79 Million	-11,534 Reduced 2.71%	414,122 $29.9 Million
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $97,080 - $131,452	692 Added 0.16%	425,656 $59.7 Million
Q2 2019 Aug 15, 2019	SELL	$157.85 - $183.09 $884,907 - $1.03 Million	-5,606 Reduced 1.3%	424,964 $77.8 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $7.97 Million - $14.6 Million	89,261 Added 26.15%	430,570 $68.5 Million

Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $1.62 Million - $2.75 Million	19,713 Added 6.13%	341,309 $32.7 Million
Q3 2018 Nov 14, 2018	BUY	$138.11 - $169.04 $7.19 Million - $8.8 Million	52,053 Added 19.31%	321,596 $45.4 Million
Q2 2018 Aug 14, 2018	BUY	$140.36 - $175.76 $12.1 Million - $15.2 Million	86,280 Added 47.08%	269,543 $42.2 Million
Q1 2018 May 09, 2018	BUY	$152.15 - $192.33 $14.5 Million - $18.3 Million	95,140 Added 107.96%	183,263 $29.5 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $323,941 - $892,758	-5,335 Reduced 5.71%	88,123 $14.5 Million
Q3 2017 Nov 15, 2017	BUY	$61.4 - $88.52 $5.74 Million - $8.27 Million	93,458	93,458 $5.82 Million

221

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $650M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.